Tesla's Downfall is Near…. Here's The Next Big Thing
This Tech Giant is About to Rock the Electric Vehicle Market and Take Over Tesla.

Click Here to see which company is secretly destroying TESLA.
Learn more.
pixel

ADTX Insider Trading (ADiTx Therapeutics)

Insider Ownership Percentage: 19.86%
Insider Buying (Last 12 Months): $18,938.90
Insider Selling (Last 12 Months): $0.00

ADiTx Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at ADiTx Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ADiTx Therapeutics Share Price & Price History

Current Price: $1.72
Price Change: Price Decrease of -0.03 (-1.71%)
As of 09/24/2021 01:00 AM ET

This chart shows the closing price history over time for ADTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!
pixel

ADiTx Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/1/2021Shahrokh ShabahangInsiderBuy490$2.93$1,435.70View SEC Filing Icon  
5/26/2021Thomas J. FarleyInsiderBuy2,500$2.68$6,700.002,500View SEC Filing Icon  
5/25/2021Corinne PankovcinCFOBuy4,220$2.56$10,803.20114,220View SEC Filing Icon  
See Full Table
Insider Trading at ADiTx Therapeutics?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for ADiTx Therapeutics and related companies.

SEC Filings (Institutional Ownership Changes) for ADiTx Therapeutics (NASDAQ:ADTX)

4.72% of ADiTx Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ADTX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

ADiTx Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/16/2021State Street Corp14,228$37K0.0%N/A0.097%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC92,015$0.24M0.0%+12.5%0.626%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.197,093$0.51M0.0%+16.6%1.342%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC69,265$0.18M0.0%+322.4%0.000%Search for SEC Filing on Google Icon
5/14/2021XTX Topco Ltd10,081$26K0.0%N/A0.000%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp19,163$49K0.0%N/A0.000%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC81,786$0.21M0.0%N/A0.000%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC16,398$34K0.0%N/A0.000%Search for SEC Filing on Google Icon
2/12/2021Credit Suisse AG51,912$0.11M0.0%N/A0.000%Search for SEC Filing on Google Icon
10/20/2020Wedbush Securities Inc.61,832$0.12M0.0%N/A0.000%Search for SEC Filing on Google Icon
10/7/2020Powell Investment Advisors LLC38,500$75K0.1%N/A0.000%Search for SEC Filing on Google Icon
8/12/2020Hudson Bay Capital Management LP108,961$0.55M0.0%N/A0.000%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
ADiTx Therapeutics logo
ADiTx Therapeutics, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune reprogramming and monitoring. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. The company is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. ADiTx Therapeutics has a license agreement with Loma Linda University and Leland Stanford Junior University. ADiTx Therapeutics, Inc. was incorporated in 2017 and is headquartered in Mountain View, California.
Read More on ADiTx Therapeutics

Today's Range

Now: $1.72
Low: $1.66
High: $1.77

50 Day Range

MA: $1.99
Low: $1.54
High: $3.04

52 Week Range

Now: $1.72
Low: $1.52
High: $6.73

Volume

2,220,463 shs

Average Volume

1,891,869 shs

Market Capitalization

$25.27 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of ADiTx Therapeutics?

ADiTx Therapeutics' top insider shareholders include:
  1. Corinne Pankovcin (CFO)
  2. Thomas J Farley (Insider)
  3. Shahrokh Shabahang (Insider)

Who are the major institutional investors of ADiTx Therapeutics?

ADiTx Therapeutics' top institutional investors include:
  1. Vanguard Group Inc. — 1.34%
  2. Geode Capital Management LLC — 0.63%
  3. Group One Trading L.P. — 0.00%
  4. Citadel Advisors LLC — 0.00%
  5. State Street Corp — 0.10%
  6. Sabby Management LLC — 0.00%

Which institutional investors are selling ADiTx Therapeutics stock?

During the last quarter, ADTX stock was sold by these institutional investors:
  1. Sabby Management LLC

Which institutional investors are buying ADiTx Therapeutics stock?

Within the previous quarter, ADTX stock was acquired by institutional investors including:
  1. Vanguard Group Inc.
  2. Citadel Advisors LLC
  3. State Street Corp
  4. Geode Capital Management LLC
  5. Group One Trading L.P.
Within the previous year, these company insiders have bought ADiTx Therapeutics stock:
  1. Corinne Pankovcin (CFO)
  2. Thomas J Farley (Insider)
  3. Shahrokh Shabahang (Insider)
Biggest Investing Moment...
Man Who Called Tesla & Bitcoin: "Nobody is Paying Attention to This"
Click here to see what you are missing